Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
07/2011
07/07/2011US20110166124 Tricyclic spirocycle derivatives and methods of use
07/07/2011US20110165699 Irinotecan immunoassay
07/07/2011US20110165183 Piperidine derivatives as jak3 inhibitors
07/07/2011CA2786089A1 Nitrogen-containing heterocyclic compound and agricultural fungicide
07/07/2011CA2786002A1 Tricyclic compounds for use as kinase inhibitors
07/07/2011CA2783213A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
07/06/2011EP2341058A2 Oligonucleotide Analogues
07/06/2011EP2341057A2 Oligonucleotide Analogues
07/06/2011EP2341046A2 Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy-camptothecin hydrochloride trihydrate
07/06/2011EP2340830A2 Hepatitis C Virus Inhibitors
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011EP2340021A1 Substituted pyrrolidine-2-carboxamides
07/06/2011EP2339919A1 Bicyclic dihydroimidazolone cgrp receptor antagonists
07/06/2011EP1643984B1 Use of parthenolide derivatives as antileukemic and cytotoxic agents
07/06/2011CN1953982B 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones
07/06/2011CN1922135B Wrinkle-diminishing agent
07/06/2011CN101538270B 8-alkyl galanthamine salt and preparation method and applications thereof
07/06/2011CN101142191B Process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide
07/05/2011US7973162 Modulators of muscarinic receptors
07/05/2011US7973160 Nitrogen-containing aromatic derivatives
07/05/2011US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly
07/05/2011CA2606147C Apoptosis promoters
07/05/2011CA2531484C Novel bioisosteres of actinonin
07/05/2011CA2436462C Inhibitors of cruzipain and other cysteine proteases
06/2011
06/30/2011WO2011079230A2 Heterocyclic compounds as janus kinase inhibitors
06/30/2011WO2011079103A1 Spiropiperidine benzylamines as beta-tryptase inhibitors
06/30/2011WO2011079023A1 Methoxatin derivatives
06/30/2011WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same
06/30/2011WO2011076744A1 Disubstituted heteroaryl-fused pyridines
06/30/2011WO2011075957A1 Tetrahydroisoquinoline compounds, preparation methods and uses thereof
06/30/2011WO2011048148A3 Glycoside derivative and uses thereof
06/30/2011WO2011045265A3 Spirocyclic derivatives as histone deacetylase inhibitors
06/30/2011US20110160460 Novel materials useful as electrolytic solutes
06/30/2011US20110160457 Methods for obtaining cyclopamine
06/30/2011US20110160451 2-Aminopyrimidine modulators of the histamine H4 receptor
06/30/2011US20110160449 Processes for the production of polymorphic forms of rifaximin
06/30/2011US20110160270 Deuterium-enriched sdx-101
06/30/2011US20110160208 Diaryl-substituted five-membered heterocycle derivative
06/30/2011US20110160198 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
06/30/2011US20110160193 New Benzothiazinone Derivatives and Their Use as Antibacterial Agents
06/30/2011US20110160182 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/30/2011US20110158991 Cytotoxic agents comprising new maytansinoids
06/30/2011CA2783475A1 Heterocyclic compounds as janus kinase inhibitors
06/29/2011EP2338925A1 -electron conjugated compound, manufacturing method therefor, and -electron conjugated polymer obtained using same
06/29/2011EP2338513A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers
06/29/2011EP1907394B1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
06/29/2011EP1888585B1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
06/29/2011CN1972932B Compounds for treating dyslipidemia
06/29/2011CN102112480A 1, 6-dihydro-2H-3-oxa-6-aza-as-indacene compounds
06/29/2011CN102112439A 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
06/28/2011US7968717 Of tiotropium bromide; chronic obstructive pulmonary disease (COPD) and asthma; storage stability, only limited hygroscopic characteristics
06/28/2011US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis
06/28/2011CA2467672C Chemokine receptor antagonists and methods of use therefor
06/28/2011CA2427206C Sulfamides as gamma-secretase inhibitors
06/23/2011WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011WO2011075565A1 SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-Aα MODULATORS
06/23/2011WO2011073378A1 Tricyclic antibiotics
06/23/2011WO2011073316A1 4-aryl-butane-1,3-diamides
06/23/2011WO2011073154A1 New ccr2 receptor antagonists and uses thereof
06/23/2011US20110152526 Methoxatin derivatives
06/23/2011US20110152517 Agent for preventing and/or treating functional gastrointestinal disorder
06/23/2011US20110152259 Nitrogen-containing heterocyclic compounds and methods of use thereof
06/23/2011US20110152252 Shiga toxin b-subunit/chemotherapeutics conjugates
06/23/2011US20110152237 Chemical Compounds
06/23/2011US20110152234 Novel Compounds
06/23/2011US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
06/23/2011US20110150835 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
06/23/2011US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011US20110150757 Compounds for inhibiting ksp kinesin activity
06/23/2011CA2784753A1 Substituted aminothiazolone indazoles as estrogen related receptor-.alpha. modulators
06/23/2011CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011CA2782464A1 New ccr2 receptor antagonists and uses thereof
06/23/2011CA2780006A1 Tricyclic antibiotics
06/22/2011EP2336134A1 Fitness assay and methods for reducing resistance of HIV to therapy
06/22/2011EP2336127A1 Tiotropium salts, method for creating same and medicinal formulations containing same
06/22/2011EP2336126A1 Tiotropium salts, method for their production and medicinal formulas containing them
06/22/2011EP2336104A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide
06/22/2011EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure
06/22/2011CN102105467A Tricyclic alkylaminomethyloxazolidinone derivatives
06/22/2011CN102105452A Substituted carbinol compound having cyclic linker
06/22/2011CN101175741B Intermediate compounds for the prepation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-C]pyrrole
06/22/2011CN101006055B 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon
06/21/2011USRE42477 Carboxylic acid derivatives, their preparation and use
06/21/2011US7964739 Through a stilbene derivative, to a pyrrolidine intermediate, followed by cyclization; asenapine is an antipsychotic agent; industrial scale
06/21/2011US7964722 Light-driven rotary molecular motors
06/21/2011US7964623 Tricyclic benzopyrane compound
06/21/2011US7964610 Buprenorphine derivatives and uses thereof
06/21/2011US7964590 Cyclopamine lactam analogs and methods of use thereof
06/21/2011US7964361 Rigidized trimethine cyanine dyes
06/21/2011CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes
06/21/2011CA2618682C Viral polymerase inhibitors
06/16/2011WO2011072064A1 S piro [chroman - 4, 4 ' - imidazol] ones as beta - secretase inhibitors
06/16/2011WO2011071136A1 Therapeutic agent for fibromyalgia
06/16/2011WO2011022694A3 Furanopyrimidine cannabinoid compounds and related methods of use
06/16/2011WO2011022692A3 Furanopyridine cannabinoid compounds and related methods of use
06/16/2011WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/16/2011US20110144321 Synthetic intermediates and processes
06/16/2011US20110144207 Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
06/16/2011US20110144178 1 ,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
06/16/2011US20110144101 Macrocyclic compounds useful as pharmaceuticals
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 298